2-14C-oxazepam (z) d 4 C -(+)and -(-1 -7-chloro-l--methyl-5-phenyl-1,3,4,5-tetrahydro-3H-l,4-benzodiazepine-2--one (s and 2) as well as 2-14C-7-chloro-4-carbamoyl-l-methyl--5-phenyl-1,3,4,5-tetrahydro-3H-l,4-benzodiazepine-2-one (9-1 were synthesised from ~arbobenzoxy-glycine-1-~~C. The overall rad
Synthesis of a labeled inhibitor of HIV-1 attachment: 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridinyl-3-yl-[U-14C]ethane-1,2-dione, BMS-488043-14C
✍ Scribed by I. Victor Ekhato; J. Kent Rinehart
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- French
- Weight
- 118 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
BMS‐488043 is a potent inhibitor of the interaction between HIV‐1 gp120 and the host cell receptor CD4. We prepared the carbon‐14‐labeled version to support preclinical studies of the compound. It was prepared from ethyl [U‐^14^C]oxalyl chloride by a sequence using Friedel–Crafts acylation reaction. The overall radiochemical yield was 82% with a purity of >99.9%. Copyright © 2010 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract Two benzodiazepine CCK antagonists __N__‐(2,3‐dihydro‐1‐[^14^C]methyl‐2‐oxo‐5‐phenyl‐1H 1,4‐benzodiazepin‐3‐yl)‐benzamide **2** and __N__‐(2,3‐dihydro‐1‐[^14^C]methyl‐2‐oxo‐5‐phenyl‐1H‐1,4‐benzodiazepin‐3‐yl)‐[^14^C]methyl‐benzamide **3** were synthesized in high yields through the reac
1-(Cyclohexyloxycarbony1oxy)ethyl 7P-[2-(2-aminothiazol-~-yl~acetamido]-3-[[[1-(2-dimethylaminoethyl~-1H-tetrazol-~-yl]thio]methyl]ceph-3-em-4-carboxylate dihydrochloride (SCE-2174), a new orally active cephalos orin, was labeled with carbon-14 starting from [l-lgC] c yc lohexanol (1) . 1 -Chloroe t
A novel fungicide, (-) (E)-1-( 2,4-di chlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)-1-penten-3-ol (S-3308 L) and i t s three o p t i c a l l y active stereoisaners were labeled w i t h carbon-14 a t the t r i a z o l e r i n g f o r use i n the metabolic and environmental f a t e studies. 1 ,2,
E ) , Bombay 400 063, I N D I A F o r pharmacokinetic and metabolism s t u d i e s i n animals and humans, Go 1C213 was l a b e l l e d w i t h carbon-14 a t t h e 2-position o f t h e 5-nitroimidazole r i n g system, i n a n o v e r a l l y i e l d o f 22% s t a r t i n g w i t h potassium[14C]t h